Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$44.91M
↑ 225% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-35.79M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.91M | +151.6% |
| 2024 | $-87.05M | -5.3% |
| 2023 | $-82.68M | -130.8% |
| 2022 | $-35.83M | +47.4% |
| 2021 | $-68.11M | -57.4% |
| 2020 | $-43.27M | -32.4% |
| 2019 | $-32.69M | -174.7% |
| 2018 | $-11.90M | -116.5% |
| 2017 | $-5.50M | - |